Epigenetics in prostate cancer treatment
Open Access
- 27 August 2021
- journal article
- review article
- Published by OAE Publishing Inc. in Journal of Translational Genetics and Genomics
- Vol. 5, 341-356
Abstract
Journal of Translational Genetics and Genomics is an open access journal, publishing articles related to single gene disorders, rare genetic disease, specific genetic syndromes, complex disease, etc.Keywords
Funding Information
- NIH (R01 CA157429 (Liu X), R01 CA192894 (Liu X), R01 CA196835 (Liu X), and R01 CA196634 (Liu X))
- DTCB internal fellowship
This publication has 102 references indexed in Scilit:
- Histone chaperones in nucleosome assembly and human diseaseNature Structural & Molecular Biology, 2013
- Histone Deacetylase Inhibitors: Emerging Mechanisms of ResistanceMolecular Pharmaceutics, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer ProgressionCancer Cell, 2010
- CBP/p300-mediated acetylation of histone H3 on lysine 56Nature, 2009
- Protein lysine methyltransferase G9a acts on non-histone targetsNature Chemical Biology, 2008
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomyBritish Journal of Cancer, 2008
- Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expressionNature Cell Biology, 2007
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcriptionNature, 2005
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004